GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hoshi Iryo-Sanki Co Ltd (TSE:7634) » Definitions » Research & Development

Hoshi Iryo-Sanki Co (TSE:7634) Research & Development : 円0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Hoshi Iryo-Sanki Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hoshi Iryo-Sanki Co's Research & Development for the three months ended in Dec. 2023 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was 円0 Mil.

Hoshi Iryo-Sanki Co Research & Development Historical Data

The historical data trend for Hoshi Iryo-Sanki Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hoshi Iryo-Sanki Co Research & Development Chart

Hoshi Iryo-Sanki Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hoshi Iryo-Sanki Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hoshi Iryo-Sanki Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hoshi Iryo-Sanki Co  (TSE:7634) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hoshi Iryo-Sanki Co Research & Development Related Terms

Thank you for viewing the detailed overview of Hoshi Iryo-Sanki Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Hoshi Iryo-Sanki Co (TSE:7634) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hoshi Iryo-Sanki Co Ltd (TSE:7634) » Definitions » Research & Development
Comparable Companies
TSE:2689 NGO:7488 SSE:3055 TSE:7681 TSE:9265 TSE:3183 TSE:3151 MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO SHSE:600739
Traded in Other Exchanges
N/A
Address
7-11-18 Iriya, Adachi-ku, Tokyo, JPN, 121-0836
Website
http://www.hosi.co.jp
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceuticals products. It offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes production and supply of medical gas, home care, care assistive devices, medical gas maintenance, and others.

Hoshi Iryo-Sanki Co (TSE:7634) Headlines

No Headlines